Teladoc Health (NYSE:TDOC) Updates Q2 Earnings Guidance

Teladoc Health (NYSE:TDOC) updated its second quarter earnings guidance on Thursday. The company provided earnings per share guidance of ($0.45)-($0.35) for the period, compared to the consensus earnings per share estimate of ($0.30). The company issued revenue guidance of $635-$660 million, compared to the consensus revenue estimate of $662.55 million. Teladoc Health also updated its FY24 guidance to ($1.10)-($0.80) EPS.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Leerink Partnrs reissued a market perform rating on shares of Teladoc Health in a research report on Monday, February 26th. Piper Sandler reduced their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating for the company in a research report on Wednesday, February 21st. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They issued an overweight rating and a $22.00 price objective for the company. Barclays reduced their price objective on shares of Teladoc Health from $26.00 to $25.00 and set an overweight rating for the company in a research report on Wednesday, February 21st. Finally, Royal Bank of Canada reduced their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an outperform rating for the company in a research report on Wednesday, February 21st. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $22.23.

Teladoc Health Price Performance

NYSE TDOC traded down $0.40 on Thursday, hitting $13.33. The stock had a trading volume of 6,550,543 shares, compared to its average volume of 4,757,382. Teladoc Health has a 52-week low of $12.85 and a 52-week high of $30.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of -10.01 and a beta of 0.94. The firm has a 50-day moving average of $15.31 and a 200-day moving average of $17.83.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Tuesday, February 20th. The health services provider reported ($0.17) EPS for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.05. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The firm had revenue of $660.50 million for the quarter, compared to analyst estimates of $670.79 million. During the same quarter in the prior year, the firm earned ($0.23) EPS. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. Equities analysts expect that Teladoc Health will post -1.07 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Andrew Turitz sold 6,190 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the transaction, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at $572,509.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock valued at $2,038,251 in the last quarter. Insiders own 1.63% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.